BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23312027)

  • 1. Cyclophilin A inhibition: targeting transition-state-bound enzyme conformations for structure-based drug design.
    Nagaraju M; McGowan LC; Hamelberg D
    J Chem Inf Model; 2013 Feb; 53(2):403-10. PubMed ID: 23312027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational plasticity of an enzyme during catalysis: intricate coupling between cyclophilin A dynamics and substrate turnover.
    McGowan LC; Hamelberg D
    Biophys J; 2013 Jan; 104(1):216-26. PubMed ID: 23332074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entropic and surprisingly small intramolecular polarization effects in the mechanism of cyclophilin A.
    Ladani ST; Hamelberg D
    J Phys Chem B; 2012 Sep; 116(35):10771-8. PubMed ID: 22891696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is so special about Arg 55 in the catalysis of cyclophilin A? insights from hybrid QM/MM simulations.
    Li G; Cui Q
    J Am Chem Soc; 2003 Dec; 125(49):15028-38. PubMed ID: 14653737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligopeptide cyclophilin inhibitors: a reassessment.
    Schumann M; Jahreis G; Kahlert V; Lücke C; Fischer G
    Eur J Med Chem; 2011 Nov; 46(11):5556-61. PubMed ID: 21963115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cis/trans isomerization in HIV-1 capsid protein catalyzed by cyclophilin A: insights from computational and theoretical studies.
    Agarwal PK
    Proteins; 2004 Aug; 56(3):449-63. PubMed ID: 15229879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach.
    Ni S; Yuan Y; Huang J; Mao X; Lv M; Zhu J; Shen X; Pei J; Lai L; Jiang H; Li J
    J Med Chem; 2009 Sep; 52(17):5295-8. PubMed ID: 19691347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for discovering chemical inhibitors of human cyclophilin a: focused library design, virtual screening, chemical synthesis and bioassay.
    Li J; Zhang J; Chen J; Luo X; Zhu W; Shen J; Liu H; Shen X; Jiang H
    J Comb Chem; 2006; 8(3):326-37. PubMed ID: 16677001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A.
    Liu Y; Jiang J; Richardson PL; Reddy RD; Johnson DD; Kati WM
    Anal Biochem; 2006 Sep; 356(1):100-7. PubMed ID: 16737676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic dynamics of an enzyme underlies catalysis.
    Eisenmesser EZ; Millet O; Labeikovsky W; Korzhnev DM; Wolf-Watz M; Bosco DA; Skalicky JJ; Kay LE; Kern D
    Nature; 2005 Nov; 438(7064):117-21. PubMed ID: 16267559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational insight into small molecule inhibition of cyclophilins.
    Sambasivarao SV; Acevedo O
    J Chem Inf Model; 2011 Feb; 51(2):475-82. PubMed ID: 21194235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the catalytic mechanism of cyclophilin A.
    Howard BR; Vajdos FF; Li S; Sundquist WI; Hill CP
    Nat Struct Biol; 2003 Jun; 10(6):475-81. PubMed ID: 12730686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A.
    Bosco DA; Eisenmesser EZ; Pochapsky S; Sundquist WI; Kern D
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5247-52. PubMed ID: 11929983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering novel chemical inhibitors of human cyclophilin A: virtual screening, synthesis, and bioassay.
    Li J; Chen J; Gui C; Zhang L; Qin Y; Xu Q; Zhang J; Liu H; Shen X; Jiang H
    Bioorg Med Chem; 2006 Apr; 14(7):2209-24. PubMed ID: 16307882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
    Sotriffer CA; Krämer O; Klebe G
    Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the catalytic mechanism of a plant beta-D-glucan glucohydrolase through structural biology using inhibitors and substrate analogues.
    Hrmova M; Fincher GB
    Carbohydr Res; 2007 Sep; 342(12-13):1613-23. PubMed ID: 17548065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexibility and inhibitor binding in cdc25 phosphatases.
    Arantes GM
    Proteins; 2010 Nov; 78(14):3017-32. PubMed ID: 20740493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein conformational populations and functionally relevant substates.
    Ramanathan A; Savol A; Burger V; Chennubhotla CS; Agarwal PK
    Acc Chem Res; 2014 Jan; 47(1):149-56. PubMed ID: 23988159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced molecular dynamics sampling of drug target conformations.
    Rodriguez-Bussey IG; Doshi U; Hamelberg D
    Biopolymers; 2016 Jan; 105(1):35-42. PubMed ID: 26352326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein dynamics and enzymatic catalysis: investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A.
    Agarwal PK; Geist A; Gorin A
    Biochemistry; 2004 Aug; 43(33):10605-18. PubMed ID: 15311922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.